GLP-1 Market
LLY $1137.82 ▲ +0.2% NVO $41.71 ▼ -1.9% PFE $27.46 ▼ -0.3% VKTX $29.52 ▼ -1.4% KLRA $12.70 ▼ -5.6% GPCR $35.50 ▼ -8.9% RHHBY $55.15 ▲ +0.4%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Thiotepa

Company
St. Jude Children's Research Hospital
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
65 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

65 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 17, 2026

Find a Clinical Trial Near Me

See recruiting studies for Thiotepa and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT00692939

    Autologous Stem Cell Transplantation for Crohn's Disease

    Not yet reported, Not yet reported Paul Szabolcs 20 participants Est. completion 2027-12 2 sites Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Recruiting NCT NCT00920972

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

    Not yet reported, Not yet reported Washington University School of Medicine 220 participants Est. completion 2031-12 28 sites Stand-alone
    Other conditions: Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies, Non-malignant Disorders
    View official trial listing →
  • Recruiting NCT NCT01949129

    Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

    Not yet reported, Not yet reported St. Anna Kinderkrebsforschung 1800 participants Est. completion 2030-06-01 119 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukaemia
    View official trial listing →
  • Recruiting NCT NCT01962415

    Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

    Not yet reported Paul Szabolcs 100 participants Est. completion 2027-11 1 site Stand-alone
    Other conditions: Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD), Hereditary Anemias, Inflammatory Conditions, Systemic Juvenile Idiopathic Arthritis (sJIA), Juvenile Rheumatoid Arthritis (JRA)
    View official trial listing →
  • Recruiting NCT NCT02508038

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

    Not yet reported University of Wisconsin, Madison 22 participants Est. completion 2027-12 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Myelodysplastic Syndrome, Myeloproliferative Syndrome, Ewing Sarcoma, Primitive Neuroectodermal Tumor, Neuroblastoma
    View official trial listing →
  • Recruiting NCT NCT02605421

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

    Not yet reported Masonic Cancer Center, University of Minnesota 12 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Recruiting NCT NCT03126916

    Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

    Not yet reported Children's Oncology Group 750 participants Est. completion 2030-09-30 164 sites Stand-alone
    Other conditions: Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma
    View official trial listing →
  • Recruiting NCT NCT03128996

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

    Not yet reported, Not yet reported Washington University School of Medicine 29 participants Est. completion 2033-04 4 sites Stand-alone
    Other conditions: Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders, Immunologic Disorders, Hemoglobinopathies, Non-malignant Disorders
    View official trial listing →
  • Recruiting NCT NCT03500731

    Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

    Not yet reported, Not yet reported Paul Szabolcs 8 participants Est. completion 2028-12 2 sites Stand-alone
    Other conditions: Idiopathic Pulmonary Fibrosis, Emphysema or COPD
    View official trial listing →
  • Recruiting NCT NCT03509961

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

    Not yet reported Pediatric Transplantation & Cellular Therapy Consortium 95 participants Est. completion 2026-07-01 24 sites
    Other conditions: B-cell Acute Lymphoblastic Leukemia
    View official trial listing →
  • Recruiting NCT NCT03630211

    Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

    Not yet reported Paul Szabolcs 8 participants Est. completion 2028-08-01 3 sites Stand-alone
    Other conditions: Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease, Pulmonary Hypertension
    View official trial listing →
  • Recruiting NCT NCT03653338

    T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

    Not yet reported, Not yet reported Paul Szabolcs 5 participants Est. completion 2028-08-01 1 site Stand-alone
    Other conditions: Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia
    View official trial listing →
  • Recruiting NCT NCT03810196

    CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

    Not yet reported Children's Hospital of Philadelphia 50 participants Est. completion 2028-07 1 site
    Other conditions: Acute Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Acute Lymphoblastic Leukemia, Mixed Lineage Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma, Juvenile Myelomonocytic Leukemia
    View official trial listing →
  • Recruiting NCT NCT03970096

    Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

    Not yet reported Fred Hutchinson Cancer Center 120 participants Est. completion 2029-12-31 3 sites Stand-alone
    Other conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm
    View official trial listing →
  • Recruiting NCT NCT03980769

    Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

    Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2028-07-01 1 site Stand-alone
    Other conditions: Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder
    View official trial listing →
  • Recruiting NCT NCT04221035

    High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 800 participants Est. completion 2032-11 142 sites Stand-alone
    Other conditions: High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
    View official trial listing →
  • Recruiting NCT NCT04528355

    Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

    Paul Szabolcs 50 participants Est. completion 2028-06-30 1 site
    Other conditions: Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD), Hereditary Anemias, Inflammatory Conditions
    View official trial listing →
  • Recruiting NCT NCT04678401

    IS-free Treg HaploHCT

    Not yet reported Dana-Farber Cancer Institute 30 participants Est. completion 2029-08-31 1 site Stand-alone
    Other conditions: Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute, Myeloid Leukemia in Relapse (Disorder), Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT04684368

    A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

    Not yet reported Children's Oncology Group 160 participants Est. completion 2029-12-21 170 sites Stand-alone
    Other conditions: Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma, Immature Teratoma, Malignant Teratoma, Mixed Germ Cell Tumor, Pineal Region Germ Cell Tumor, Pineal Region Immature Teratoma, Pineal Region Yolk Sac Tumor, Suprasellar Germ Cell Tumor
    View official trial listing →
  • Recruiting NCT NCT04708054

    Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 324 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT05427136

    Early Pulmonary Dysfunction in Childhood Cancer Patients

    University Children's Hospital Basel 140 participants Est. completion 2051-06 5 sites
    Other conditions: Pulmonary Dysfunction
    View official trial listing →
  • Recruiting NCT NCT05757817

    Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae

    Not yet reported Institut Claudius Regaud 40 participants Est. completion 2027-01 4 sites
    Other conditions: Head and Neck Cancer, Oral Cavity Cancer, Oropharynx Cancer
    View official trial listing →
  • Recruiting NCT NCT05884333

    Cord Blood Transplant in Adults With Blood Cancers

    Not yet reported Memorial Sloan Kettering Cancer Center 54 participants Est. completion 2028-05-22 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML), Myelodysplastic Syndromes (MDS), Myeloproliferative Disorder, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05931328

    The Study of the Combination of Thiotepa and Pomalidomide for the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma Patients.

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 28 participants Est. completion 2026-10 1 site Stand-alone
    Other conditions: Relapsed or Refractory (R/R) Primary Central Nervous System Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06013423

    Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

    Not yet reported Fred Hutchinson Cancer Center 54 participants Est. completion 2032-10-31 1 site Stand-alone
    Other conditions: Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma, Chronic Myeloid Leukemia, BCR-ABL1 Positive
    View official trial listing →
  • Recruiting NCT NCT06060782

    Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine

    Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University 28 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult
    View official trial listing →
  • Recruiting NCT NCT06111612

    Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50 participants Est. completion 2027-01-01 1 site
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Neoplasm, Chronic Myelomonocytic Leukemia, Myeloid Sarcoma, Extramedullary Myeloid Tumor
    View official trial listing →
  • Recruiting NCT NCT06158828

    Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

    Not yet reported, Not yet reported Washington University School of Medicine 68 participants Est. completion 2030-05-31 1 site Stand-alone
    Other conditions: AML, Childhood, Aml, Acute Myeloid Leukemia, Pediatric, Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06172296

    Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

    Not yet reported National Cancer Institute (NCI) 478 participants Est. completion 2029-12-31 179 sites Stand-alone
    Other conditions: Ganglioneuroblastoma, Nodular, Neuroblastoma
    View official trial listing →
  • Recruiting NCT NCT06193759

    Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

    Not yet reported Children's National Research Institute 12 participants Est. completion 2032-12-29 1 site Stand-alone
    Other conditions: Medulloblastoma, Childhood, Atypical Teratoid/Rhabdoid Tumor of CNS, Embryonal Tumor With Multilayered Rosettes, Pineoblastoma, Embryonal Brain Tumor Not Otherwise Specified, Ependymoma
    View official trial listing →
  • Recruiting NCT NCT06195891

    Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

    Not yet reported City of Hope Medical Center 33 participants Est. completion 2030-03-22 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT06199427

    PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

    Not yet reported Federal Research Institute of Pediatric Hematology, Oncology and Immunology 100 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Inborn Errors of Immunity
    View official trial listing →
  • Recruiting NCT NCT06230055

    Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis

    Not yet reported Fudan University 37 participants Est. completion 2027-01-01 1 site Stand-alone
    Other conditions: HER2-negative Breast Cancer, Leptomeningeal Metastasis
    View official trial listing →
  • Recruiting NCT NCT06252870

    Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation

    Not yet reported Nantes University Hospital 82 participants Est. completion 2028-07-18 3 sites
    Other conditions: Graft Versus Host Disease, Hematologic Malignancy
    View official trial listing →
  • Recruiting NCT NCT06543992

    Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal Metastasis

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 22 participants Est. completion 2026-12-13 1 site Stand-alone
    Other conditions: Leptomeningeal Metastasis of Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06674382

    Haplo-HSCT for Myelofibrosis

    Not yet reported Peking University People's Hospital 39 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT06687772

    CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

    Not yet reported Washington University School of Medicine 36 participants Est. completion 2030-07-31 1 site Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06807606

    Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center 35 participants Est. completion 2029-11-30 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Recruiting NCT NCT06830421

    Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients

    Not yet reported University Hospital Freiburg 340 participants Est. completion 2031-08-31 35 sites Stand-alone
    Other conditions: Primary Central Nervous System Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06832267

    Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL

    Not yet reported Zhejiang Cancer Hospital 44 participants Est. completion 2028-02-13 1 site Stand-alone
    Other conditions: Primary Central Nervous System Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06861244

    Embryonal Tumor With Multilayered Rosettes

    Not yet reported University of California, San Francisco 70 participants Est. completion 2032-03-31 8 sites Stand-alone
    Other conditions: Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Multilayered Rosettes, Nos
    View official trial listing →
  • Recruiting NCT NCT06869265

    Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia

    Not yet reported Peking University People's Hospital 56 participants Est. completion 2029-04-01 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia (AML), High Risk Acute Myeloid Leukemia(AML), Relapsed/Refractory Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Recruiting NCT NCT06872333

    Allo HSCT for High Risk Hemoglobinopathies

    Not yet reported Masonic Cancer Center, University of Minnesota 62 participants Est. completion 2032-06-01 1 site Stand-alone
    Other conditions: Graft Failure, Sickle Cell Disease, Hemoglobinopathies
    View official trial listing →
  • Recruiting NCT NCT06942039

    Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

    Not yet reported C17 Council 15 participants Est. completion 2032-12-31 12 sites Stand-alone
    Other conditions: CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor, Medulloblastoma, Childhood, Medulloblastoma, Group 3, Medulloblastoma, Group 4, Pineoblastoma, Neuroblastoma, Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Abundant Neuropil and True Rosettes, Ependymoblastoma, Medulloepithelioma, CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Nos
    View official trial listing →
  • Recruiting NCT NCT06946407

    Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma

    Not yet reported FengYan Jin 41 participants Est. completion 2029-12-01 1 site Stand-alone
    Other conditions: Primary Central Nervous System Lymphoma (PCNSL), CNS Lymphoma Treatment
    View official trial listing →
  • Recruiting NCT NCT07014943

    High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma

    Not yet reported Sichuan University 34 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Primary Central Nervous System Lymphoma (PCNSL)
    View official trial listing →
  • Recruiting NCT NCT07052370

    TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 30 participants Est. completion 2030-12 1 site Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Recruiting NCT NCT07059741

    Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL

    Not yet reported The First Affiliated Hospital of Soochow University 20 participants Est. completion 2028-12-10 1 site Stand-alone
    Other conditions: Aggressive B-Cell Non-Hodgkin&#39;s Lymphoma (NHL)
    View official trial listing →
  • Recruiting NCT NCT07074470

    Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL

    Not yet reported The First Affiliated Hospital of Soochow University 40 participants Est. completion 2032-01-02 1 site Stand-alone
    Other conditions: Primary Central Nervous System Lymphoma (PCNSL)
    View official trial listing →
  • Recruiting NCT NCT07191431

    A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）

    Not yet reported Ruijin Hospital 25 participants Est. completion 2029-09-02 1 site Stand-alone
    Other conditions: Lymphoma Cns
    View official trial listing →
  • Recruiting NCT NCT07193654

    Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 38 participants Est. completion 2028-04-01 1 site Stand-alone
    Other conditions: Glioblastoma (GBM)
    View official trial listing →
  • Recruiting NCT NCT07249346

    Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

    Not yet reported Hannah Choe, MD 124 participants Est. completion 2027-06-01 3 sites Stand-alone
    Other conditions: Leukemia, Myelodysplasia, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Recruiting NCT NCT07252050

    Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

    Not yet reported, Not yet reported Arkansas Children's Hospital Research Institute 24 participants Est. completion 2029-11-19 4 sites Stand-alone
    Other conditions: Sickle Cell Disease, Hematopoetic Stem Cell Transplant, Haploidentical Hematopoietic Stem Cell Transplant, Haploidentical Stem Cell Transplantation, Graft Failure
    View official trial listing →
  • Recruiting NCT NCT07257419

    CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

    Not yet reported St. Jude Children's Research Hospital 70 participants Est. completion 2035-12 1 site Stand-alone
    Other conditions: Relapsed Pediatric ALL, Hematopoietic Cell Transplantation, Hematologic Malignancy
    View official trial listing →
  • Recruiting NCT NCT07263425

    Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Leptomeningeal Metastasis

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 26 participants Est. completion 2027-10-27 1 site Stand-alone
    Other conditions: Leptomeningeal Metastasis of HER2-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07350850

    A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL

    Not yet reported Tongji Hospital 77 participants Est. completion 2029-06-30 4 sites
    Other conditions: PCNSL, Primary Central Nervous System Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07416890

    Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma

    Not yet reported Zhejiang Cancer Hospital 24 participants Est. completion 2030-08-05 1 site Stand-alone
    Other conditions: Pirtobrutinib, Sintilimab, Central Nervous System Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07481669

    ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 45 participants Est. completion 2028-03-31 1 site Stand-alone
    Other conditions: Lymphoma Patients With High-risk of Central Nervous System Relapse
    View official trial listing →
  • Recruiting NCT NCT07511725

    Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 38 participants Est. completion 2029-01-04 1 site Stand-alone
    Other conditions: Glioblastoma (GBM)
    View official trial listing →
  • Recruiting NCT NCT07538635

    CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma With High-risk Factors.

    Not yet reported Zhejiang Cancer Hospital 20 participants Est. completion 2028-02-29 1 site Stand-alone
    Other conditions: High-risk R/R LBCL
    View official trial listing →
  • Recruiting NCT NCT07565220

    Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

    Not yet reported Sawa Ito, MD 48 participants Est. completion 2030-11-01 1 site Stand-alone
    Other conditions: Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Acute Leukemia, Myelodysplastic Syndrome(MDS), Myeloproliferative Neoplasm (MPN)
    View official trial listing →
  • Recruiting NCT NCT07566377

    Cord Blood Transplantation in Children and Young Adults With Blood Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 71 participants Est. completion 2030-04-28 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Leukemia, Lymphoma, Graft-versus-host Disease
    View official trial listing →
  • Recruiting NCT NCT07588594

    Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia

    Not yet reported Peking University People's Hospital 31 participants Est. completion 2028-05 1 site Stand-alone
    Other conditions: Chronic Myelomonocytic Leukemia (CMML)
    View official trial listing →
  • Recruiting NCT NCT07604987

    R-PMDT Regimen in Newly Diagnosed PCNSL

    Not yet reported Zou Dehui 33 participants Est. completion 2030-05-20 1 site Stand-alone
    Other conditions: Primary Central Nervous System (CNS) Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07616154

    Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease

    Not yet reported St. Jude Children's Research Hospital 45 participants Est. completion 2035-09 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT00001498

    A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer

    Not yet reported National Cancer Institute (NCI) 55 participants Est. completion 2000-12 1 site
    Other conditions: Breast Cancer, Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00002471

    Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2003-01 4 sites
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00002508

    Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors

    Not yet reported, Not yet reported Temple University Est. completion 2001-09 1 site
    Other conditions: Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00002515

    Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2005-04 1 site
    Other conditions: Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lymphoma, Neuroblastoma, Ovarian Cancer, Retinoblastoma, Sarcoma, Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00002534

    Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2003-04 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT00002616

    Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

    Not yet reported University of Illinois at Chicago 36 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002619

    Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors

    Not yet reported NYU Langone Health 60 participants 1 site
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00002680

    Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer

    Not yet reported Yale University 40 participants Est. completion 2000-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002704

    Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 156 participants 70 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002718

    T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia

    Not yet reported Memorial Sloan Kettering Cancer Center 31 participants Est. completion 2008-10 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00002755

    Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

    Not yet reported Scottish Cancer Therapy Network 600 participants Est. completion 1999-06 21 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00002772

    S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

    Not yet reported SWOG Cancer Research Network 602 participants Est. completion 2004-02 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00002780

    Biological Therapy in Treating Women With Metastatic Breast Cancer

    Not yet reported, Not yet reported St. Luke's Medical Center 60 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002836

    Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer

    Not yet reported M.D. Anderson Cancer Center 184 participants Est. completion 2006-03-09 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002870

    High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer

    Not yet reported UNICANCER 180 participants Est. completion 2002-01 32 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002942

    Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer

    Not yet reported Wake Forest University Health Sciences 136 participants Est. completion 2003-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002977

    Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission

    Not yet reported Fred Hutchinson Cancer Center 45 participants 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Status unknown NCT NCT00003064

    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer

    Not yet reported, Not yet reported Herbert Irving Comprehensive Cancer Center 30 participants 1 site
    Other conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    View official trial listing →
  • Completed NCT NCT00003068

    High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

    Not yet reported University of Arizona 30 participants Est. completion 2002-11 1 site
    Other conditions: Breast Cancer, Drug/Agent Toxicity by Tissue/Organ
    View official trial listing →
  • Completed NCT NCT00003080

    Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2001-05 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00003081

    Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma

    Not yet reported Fred Hutchinson Cancer Center 16 participants Est. completion 2002-01 1 site
    Other conditions: Sarcoma
    View official trial listing →
  • Terminated NCT NCT00003086

    Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer

    Not yet reported, Not yet reported Louisiana State University Health Sciences Center Shreveport 12 participants Est. completion 2001-01-28 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003101

    Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

    Not yet reported Memorial Sloan Kettering Cancer Center 60 participants Est. completion 2002-01 7 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00003141

    Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

    Not yet reported Children's Oncology Group 94 participants Est. completion 2011-10 71 sites Stand-alone
    Other conditions: Brain Tumors, Central Nervous System Tumors, Neuroblastoma, Sarcoma
    View official trial listing →
  • Completed NCT NCT00003146

    Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2001-06 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00003173

    High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center 36 participants Est. completion 2003-05 2 sites
    Other conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Retinoblastoma, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00003194

    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors

    Not yet reported Seattle Children's Hospital 24 participants Est. completion 2002-12-19 2 sites
    Other conditions: Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00003199

    Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

    Not yet reported Fred Hutchinson Cancer Center 50 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Inflammatory Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00003273

    Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

    Not yet reported NYU Langone Health 19 sites
    Other conditions: Brain and Central Nervous System Tumors, Neuroblastoma, Retinoblastoma, Sarcoma
    View official trial listing →
  • Completed NCT NCT00003297

    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer

    Not yet reported, Not yet reported Georgetown University 50 participants Est. completion 2001-01 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00003398

    Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported University of Maryland, Baltimore 45 participants Est. completion 2000-05 1 site
    Other conditions: Anemia, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00003412

    Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation

    Not yet reported Beth Israel Deaconess Medical Center 35 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00003680

    Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

    Not yet reported Scottish Cancer Therapy Network 300 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003816

    Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

    Not yet reported, Not yet reported Roswell Park Cancer Institute 361 participants Est. completion 2019-07-12 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Nonmalignant Neoplasm, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00003846

    Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors

    Not yet reported Children's Oncology Group 25 participants Est. completion 2007-03 13 sites Stand-alone
    Other conditions: Brain and Central Nervous System Tumors, Neuroblastoma
    View official trial listing →
  • Terminated NCT NCT00003852

    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

    Not yet reported UNICANCER 45 participants Est. completion 2000-03 18 sites
    Other conditions: Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00003877

    Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

    Not yet reported, Not yet reported Roswell Park Cancer Institute 30 participants Est. completion 2000-12 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003899

    Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2001-11 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00003926

    Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

    Not yet reported Masonic Cancer Center, University of Minnesota 13 participants Est. completion 2003-08 1 site Stand-alone
    Other conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Chordoma, Kidney Cancer, Liver Cancer, Neuroblastoma, Ovarian Cancer, Retinoblastoma, Sarcoma
    View official trial listing →
  • Completed NCT NCT00003972

    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

    Not yet reported Fred Hutchinson Cancer Center 280 participants Est. completion 2003-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004092

    Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer

    Not yet reported City of Hope Medical Center 72 participants Est. completion 2013-12 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004172

    Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

    Not yet reported Northwestern University Est. completion 2003-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004174

    Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

    Not yet reported Northwestern University 30 participants Est. completion 2008-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004900

    Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

    Not yet reported Hackensack Meridian Health Est. completion 2004-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00004906

    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

    Not yet reported Hackensack Meridian Health Est. completion 2001-06 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00005092

    Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported M.D. Anderson Cancer Center 7 participants Est. completion 2002-08-28 3 sites Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00005798

    Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 209 participants Est. completion 2007-07 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00006123

    Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer

    Not yet reported, Not yet reported Beth Israel Deaconess Medical Center Est. completion 2000-07 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00007982

    Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

    Not yet reported Herbert Irving Comprehensive Cancer Center 30 participants Est. completion 2008-05 1 site
    Other conditions: Brain and Central Nervous System Tumors, Head and Neck Cancer, Lymphoma
    View official trial listing →
  • Completed NCT NCT00008008

    Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma

    Not yet reported Herbert Irving Comprehensive Cancer Center 40 participants Est. completion 2008-05 2 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00008203

    Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer

    Not yet reported Herbert Irving Comprehensive Cancer Center Est. completion 2008-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00012311

    Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

    Not yet reported Herbert Irving Comprehensive Cancer Center 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00017368

    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma

    Not yet reported Children's Oncology Group 42 participants Est. completion 2012-01 9 sites Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Terminated NCT NCT00020722

    Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer

    Not yet reported Barbara Ann Karmanos Cancer Institute 7 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00025077

    Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors

    Not yet reported Children's Cancer and Leukaemia Group 50 participants Est. completion 2011-04 21 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Status unknown NCT NCT00025324

    Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors

    Not yet reported Children's Hospital Los Angeles 4 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00025558

    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer

    Not yet reported NYU Langone Health 4 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00027937

    Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2007-11 1 site
    Other conditions: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00028730

    Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 25 participants Est. completion 2008-06 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00038857

    Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases

    Not yet reported M.D. Anderson Cancer Center 29 participants Est. completion 2009-06 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00040872

    Multiple Therapies in Treating Patients With Advanced Neuroblastoma

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2007-01 1 site
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00045539

    Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

    Not yet reported New Approaches to Brain Tumor Therapy Consortium Est. completion 2006-01 9 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00047320

    Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors

    Not yet reported Children's Oncology Group 104 participants Est. completion 2009-02 106 sites Stand-alone
    Other conditions: Brain Tumor, Central Nervous System Tumors, Childhood Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00060255

    High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

    Not yet reported Roswell Park Cancer Institute 451 participants Est. completion 2013-02 1 site
    Other conditions: Breast Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00066417

    Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 51 participants Est. completion 2007-01 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00067002

    Randomized Double Cord Blood Transplant Study

    Not yet reported M.D. Anderson Cancer Center 110 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Leukemia, Lymphocytic, Acute, Leukemia, Myelocytic, Acute, Leukemia, Myeloid, Chronic, Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT00078988

    High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas

    Not yet reported Children's Oncology Group 1 participants Est. completion 2006-09 59 sites Stand-alone
    Other conditions: Brain Tumor, Central Nervous System Tumor
    View official trial listing →
  • Withdrawn NCT NCT00101140

    Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

    Not yet reported Eastern Cooperative Oncology Group
    Other conditions: Adult Acute Erythroid Leukemia, Adult Acute Monoblastic and Acute Monocytic Leukemia, Adult Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00104975

    Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported Yale University 20 participants Est. completion 2008-05 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00112567

    Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 20 participants Est. completion 2007-07 2 sites
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00141765

    Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers

    Not yet reported University of Michigan Rogel Cancer Center 25 participants Est. completion 2010-02 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Wilms Tumor, Carcinoma, Round Cell, Nasopharyngeal Cancer, Brain Tumor, Recurrent
    View official trial listing →
  • Completed NCT NCT00143559

    Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 17 participants Est. completion 2009-01 1 site
    Other conditions: Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Paroxysmal Nocturnal Hemoglobinuria, Hodgkin's Lymphoma, Non-Hodgkin Lymphoma
    View official trial listing →
  • Terminated NCT NCT00145587

    Stem Cell Transplantation for Children Affected With Osteopetrosis

    Not yet reported St. Jude Children's Research Hospital 15 participants Est. completion 2009-02 1 site
    Other conditions: Osteopetrosis
    View official trial listing →
  • Completed NCT NCT00145613

    Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies

    Not yet reported St. Jude Children's Research Hospital 25 participants Est. completion 2009-02 1 site
    Other conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Secondary AML, Myelodysplastic Syndrome (MDS), Secondary MDS, Chronic Myeloid Leukemia, Juvenile Myelomonocytic Leukemia (JMML), Paroxysmal Nocturnal Hemoglobinuria (PNH), Lymphoma, Non-Hodgkin, Hodgkin Disease
    View official trial listing →
  • Completed NCT NCT00145626

    HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 40 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplasia, Chronic Myeloid Leukemia, Histiocytosis
    View official trial listing →
  • Completed NCT NCT00152113

    Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound

    Not yet reported St. Jude Children's Research Hospital 5 participants Est. completion 2009-01 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT00152139

    Stem Cell Transplantation for Patients With Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 33 participants Est. completion 2009-01 1 site
    Other conditions: Acute Lymphoblastic Leukemias, Acute Myelocytic Leukemia, Chronic Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Hemoglobinuria, Paroxysmal, Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT00160355

    Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome

    Not yet reported St. Jude Children's Research Hospital 4 participants Est. completion 2009-02 1 site
    Other conditions: Wiskott-Aldrich Syndrome
    View official trial listing →
  • Completed NCT NCT00179803

    Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors

    Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago 24 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Glioblastoma, Astrocytoma, Pineoblastoma, Rhabdoid Tumor, Supratentorial Neoplasms
    View official trial listing →
  • Status unknown NCT NCT00180791

    High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 71 participants 1 site
    Other conditions: Medulloblastoma, Brain Tumors, Neuroectodermal Tumors, Primitive
    View official trial listing →
  • Completed NCT NCT00182793

    Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

    Not yet reported City of Hope Medical Center 32 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00186823

    Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 57 participants Est. completion 2009-01 1 site
    Other conditions: Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML), Juvenile Myelomonocytic Leukemia(JMML), Hemoglobinuria, Paroxysmal Nocturnal (PNH), Lymphoma, Non-Hodgkin (NHL), Myelodysplastic Syndrome (MDS)
    View official trial listing →
  • Completed NCT NCT00202917

    Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies

    Not yet reported, Not yet reported University Hospital Tuebingen 61 participants Est. completion 2010-12 7 sites
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT00238433

    Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

    Not yet reported OHSU Knight Cancer Institute 37 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00244010

    Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias

    Not yet reported St. Jude Children's Research Hospital 4 participants Est. completion 2009-02 1 site
    Other conditions: Anemia, Aplastic, Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia, Kostmann Syndrome
    View official trial listing →
  • Completed NCT NCT00295971

    Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease

    Not yet reported University of California, San Francisco 21 participants Est. completion 2011-12 2 sites Stand-alone
    Other conditions: Congenital Amegakaryocytic Thrombocytopenia, Leukemia, Myelodysplastic Syndromes, Severe Congenital Neutropenia
    View official trial listing →
  • Completed NCT NCT00303810

    Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma

    Not yet reported Universitätsklinikum Hamburg-Eppendorf 567 participants 1 site
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Status unknown NCT NCT00313521

    Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors

    Not yet reported Children's Cancer and Leukaemia Group 30 participants
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Status unknown NCT NCT00317408

    Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma

    Not yet reported European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma 96 participants 98 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00336024

    Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

    Not yet reported Children's Oncology Group 91 participants Est. completion 2025-09-30 145 sites Stand-alone
    Other conditions: Anaplastic Medulloblastoma, Medulloblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    View official trial listing →
  • Completed NCT NCT00357396

    Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center 10 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00376480

    Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

    Not yet reported Dana-Farber Cancer Institute 19 participants Est. completion 2018-05-16 6 sites Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00382109

    Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

    Not yet reported Children's Oncology Group 146 participants Est. completion 2017-06-30 50 sites Stand-alone
    Other conditions: B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Terminated NCT NCT00392782

    Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease

    Not yet reported Masonic Cancer Center, University of Minnesota 24 participants Est. completion 2011-05 9 sites Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00392886

    Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors

    Not yet reported Children's Hospital Los Angeles 120 participants 37 sites Stand-alone
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00423514

    Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 38 participants Est. completion 2021-06-18 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00429182

    Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer

    Not yet reported M.D. Anderson Cancer Center 32 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Breast Cancer, Metastatic Breast Carcinoma, Invasive Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT00432094

    Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors

    Not yet reported Masonic Cancer Center, University of Minnesota 23 participants Est. completion 2021-03 1 site Stand-alone
    Other conditions: Childhood Germ Cell Tumor, Ovarian Cancer, Teratoma
    View official trial listing →
  • Terminated NCT NCT00448266

    Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

    Not yet reported, Not yet reported The Netherlands Cancer Institute 12 participants Est. completion 2011-02 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00450983

    Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases

    Not yet reported Fred Hutchinson Cancer Center 1 participants Est. completion 2010-07 2 sites
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00462787

    Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia

    Not yet reported Memorial Sloan Kettering Cancer Center 23 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00528437

    Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

    Not yet reported NYU Langone Health 46 participants Est. completion 2017-12-30 17 sites
    Other conditions: Brain Tumors
    View official trial listing →
  • Completed NCT NCT00536601

    High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

    Not yet reported Roswell Park Cancer Institute 174 participants Est. completion 2018-07-09 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET), Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-cell Lymphoma, Plasma Cell Neoplasm, Primary Systemic Amyloidosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Neuroblastoma, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Multiple Myeloma, Regional Neuroblastoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00554788

    Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma

    Not yet reported Children's Oncology Group 60 participants Est. completion 2024-12-31 73 sites Stand-alone
    Other conditions: Extraocular Retinoblastoma
    View official trial listing →
  • Completed NCT NCT00566696

    Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies

    Not yet reported St. Jude Children's Research Hospital 73 participants Est. completion 2020-02-06 1 site
    Other conditions: Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML), Juvenile Myelomonocytic Leukemia (JMML), Hemoglobinuria, Paroxysmal Nocturnal (PNH), Hodgkin Lymphoma, Lymphoma, Non-Hodgkin (NHL), Myelodysplastic Syndrome (MDS)
    View official trial listing →
  • Completed NCT NCT00567567

    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma

    Not yet reported Children's Oncology Group 665 participants Est. completion 2022-03-31 190 sites Stand-alone
    Other conditions: Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
    View official trial listing →
  • Terminated NCT NCT00582816

    Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors

    Not yet reported, Not yet reported University of Wisconsin, Madison 9 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Leukemia, Solid Tumors
    View official trial listing →
  • Completed NCT NCT00584428

    High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer

    Not yet reported University of Oklahoma 61 participants Est. completion 2002-03 1 site Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00587054

    Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders

    Not yet reported Memorial Sloan Kettering Cancer Center 129 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Allogeneic Stem Cell Transplant, Leukemia, Non-Hodgkins, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, Paroxysmal Nocturnal Hemoglobinuria (PNH)
    View official trial listing →
  • Completed NCT NCT00588523

    Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma

    Not yet reported Memorial Sloan Kettering Cancer Center 60 participants Est. completion 2023-02-02 3 sites Stand-alone
    Other conditions: CNS Cancer, CNS BRAIN
    View official trial listing →
  • Terminated NCT NCT00593554

    Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies

    Not yet reported Sherif S. Farag 9 participants Est. completion 2017-07-28 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplasia, Chronic Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00596154

    Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

    Not yet reported Memorial Sloan Kettering Cancer Center 33 participants Est. completion 2023-02-02 3 sites Stand-alone
    Other conditions: CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00607984

    Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors

    Not yet reported Rabin Medical Center 20 participants 1 site Stand-alone
    Other conditions: Central Nervous System Tumors, Tumors
    View official trial listing →
  • Withdrawn NCT NCT00621036

    Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2008-12-08 1 site Stand-alone
    Other conditions: Brain and Central Nervous System Tumors, Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer
    View official trial listing →
  • Terminated NCT NCT00623077

    MT2004-30: Tomotherapy for Solid Tumors

    Not yet reported Masonic Cancer Center, University of Minnesota 23 participants Est. completion 2016-10 1 site Stand-alone
    Other conditions: Brain and Central Nervous System Tumors, Kidney Cancer, Liver Cancer, Retinoblastoma, Sarcoma
    View official trial listing →
  • Completed NCT NCT00644371

    Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)

    Not yet reported Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 20 participants Est. completion 2013-02-04 14 sites Stand-alone
    Other conditions: Non-Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00647049

    Freiburg ZNS-NHL Study

    Not yet reported University Hospital Freiburg 78 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Primary Non Hodgkin Lymphoma of the Central Nervous System
    View official trial listing →
  • Completed NCT NCT00653068

    Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System

    Not yet reported Children's Oncology Group 70 participants Est. completion 2024-03-31 94 sites Stand-alone
    Other conditions: Childhood Atypical Teratoid/Rhabdoid Tumor
    View official trial listing →
  • Completed NCT NCT00719888

    Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

    Not yet reported Fred Hutchinson Cancer Center 135 participants Est. completion 2024-12-19 3 sites Stand-alone
    Other conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Burkitt Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Follicular Lymphoma, Lymphoblastic Lymphoma, Lymphoplasmacytic Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Non-Hodgkin Lymphoma, Plasma Cell Myeloma, Prolymphocytic Leukemia, Refractory Anemia, Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT00739141

    Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    Not yet reported Memorial Sloan Kettering Cancer Center 86 participants Est. completion 2021-10-15 1 site Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma, Chronic Myelogenous Leukemia, Hodgkins Lymphoma
    View official trial listing →
  • Completed NCT NCT00744692

    Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders

    Not yet reported Duke University 22 participants Est. completion 2014-04 1 site
    Other conditions: Non Malignant Disorders, Immunodeficiencies, Congenital Marrow Failures, Hemoglobinopathies, Inborn Errors of Metabolism, Sickle Cell, Thalassemia, Lysosomal Storage Disease
    View official trial listing →
  • Completed NCT NCT00749723

    Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children

    Not yet reported, Not yet reported University Hospital, Bonn 174 participants Est. completion 2016-01-31 54 sites Stand-alone
    Other conditions: Recurrent Brain Tumors, Supratentorial PNETs, Medulloblastomas, Ependymomas
    View official trial listing →
  • Status unknown NCT NCT00790413

    Haploidentical Stem Cell Transplantation in Neuroblastoma

    Not yet reported Lund University Hospital 15 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00793845

    Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma

    Not yet reported Samsung Medical Center 40 participants Est. completion 2018-01 1 site Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00801216

    High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement

    Not yet reported Andrés José Maria Ferreri 40 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: B-cell Lymphomas
    View official trial listing →
  • Terminated NCT NCT00801931

    Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

    Not yet reported, Not yet reported Columbia University 1 participants Est. completion 2009-05-05 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Neuroblastoma, Immunodeficiencies, Anemia
    View official trial listing →
  • Completed NCT NCT00824135

    Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 34 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Terminated NCT NCT00851110

    Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors

    Not yet reported University Medical Center Groningen 50 participants 10 sites
    Other conditions: High-Risk Breast Cancer
    View official trial listing →
  • Completed NCT NCT00857389

    Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies

    Not yet reported M.D. Anderson Cancer Center 60 participants Est. completion 2019-03-09 1 site Stand-alone
    Other conditions: Stem Cell Transplantation, Leukemia, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00863460

    Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients

    Not yet reported Institut Curie 140 participants Est. completion 2026-05 23 sites
    Other conditions: Primary Central Nervous System Lymphoma
    View official trial listing →
  • Completed NCT NCT00867178

    Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System

    Not yet reported National Cancer Institute (NCI) 33 participants Est. completion 2021-12-22 15 sites Stand-alone
    Other conditions: Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified
    View official trial listing →
  • Completed NCT NCT00886522

    Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies

    Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 23 participants Est. completion 2013-05 1 site
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Terminated NCT NCT00914940

    Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD

    Not yet reported Fred Hutchinson Cancer Center 41 participants Est. completion 2020-05-26 2 sites Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Terminated NCT NCT00916045

    Pilot Study of Unrelated Cord Blood Transplantation

    Not yet reported King's College Hospital NHS Trust 40 participants Est. completion 2012-03 1 site
    Other conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Leukemia, Lymphoblastic, Acute, Lymphoma, Non-Hodgkin, Hodgkin Disease, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00936156

    Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 68 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Metastatic, Cerebral Primitive Neuroectodermal Tumors
    View official trial listing →
  • Completed NCT NCT00943800

    Combined Haploidentical-Cord Blood Transplantation for Adults and Children

    Not yet reported University of Chicago 87 participants Est. completion 2018-09 1 site Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, Lymphoma
    View official trial listing →
  • Terminated NCT NCT00961142

    Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia

    Not yet reported University Hospital Tuebingen 23 participants Est. completion 2015-12-30 8 sites
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
    View official trial listing →
  • Terminated NCT NCT00966498

    Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors

    Not yet reported Emory University 3 participants Est. completion 2011-07 2 sites Stand-alone
    Other conditions: High Risk Solid Tumors, Recurrent Solid Tumors
    View official trial listing →
  • Withdrawn NCT NCT00972101

    Infusion of Expanded Cord Blood T Cells

    Not yet reported M.D. Anderson Cancer Center Est. completion 2011-09 Stand-alone
    Other conditions: Stem Cell Transplantation, Leukemia, Lymphoma, Pediatric Disorders
    View official trial listing →
  • Completed NCT NCT00978471

    Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma

    Not yet reported Centre Leon Berard 44 participants Est. completion 2018-10-29 23 sites Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT00998361

    Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas

    Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 140 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Ewing, Soft Tissue Sarcoma
    View official trial listing →
  • Completed NCT NCT01005576

    Reduced Intensity Transplant Conditioning Regimen for Severe Thalassemia

    Not yet reported Washington University School of Medicine 21 participants Est. completion 2014-07 18 sites Stand-alone
    Other conditions: Severe Thalassemia
    View official trial listing →
  • Completed NCT NCT01010217

    Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

    Not yet reported M.D. Anderson Cancer Center 176 participants Est. completion 2017-10-05 1 site Stand-alone
    Other conditions: Blood Stem Cell Transplant Failure, Leukemia, Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01011920

    Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

    Not yet reported International Extranodal Lymphoma Study Group (IELSG) 227 participants Est. completion 2024-12-19 54 sites Stand-alone
    Other conditions: Central Nervous System Lymphoma
    View official trial listing →
  • Completed NCT NCT01025778

    Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia

    Not yet reported Lund University Hospital 7 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01049854

    CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

    Not yet reported New York Medical College 20 participants Est. completion 2018-08 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Bone Marrow Failure, Immunodeficiencies, Histiocytosis, Sickle Cell Disease, Beta Thalassemia, Inborn Errors of Metabolism
    View official trial listing →
  • Terminated NCT NCT01050439

    Unrelated Donor Transplant for Malignant and Non-Malignant Disorders

    Not yet reported Columbia University 22 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Bone Marrow Failure Syndromes, Immunodeficiencies, Histiocytosis
    View official trial listing →
  • Terminated NCT NCT01050764

    Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells

    Not yet reported, Not yet reported Everett Meyer 10 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Leukemia, Acute, Chronic Myelogenous Leukemia (CML), Myelodysplastic Syndrome (MDS), Non-Hodgkin Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL)
    View official trial listing →
  • Active, not recruiting NCT NCT01057069

    Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer

    Not yet reported, Not yet reported The Netherlands Cancer Institute 310 participants Est. completion 2029-12 14 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01068301

    A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation

    Not yet reported St. Jude Children's Research Hospital 12 participants Est. completion 2013-10 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01091168

    Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer

    Not yet reported Pierre Fabre Medicament 594 participants Est. completion 2014-01 80 sites
    Other conditions: Breast Cancer, Metastases
    View official trial listing →
  • Completed NCT NCT01119066

    HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    Not yet reported Memorial Sloan Kettering Cancer Center 422 participants Est. completion 2021-03-30 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT01148173

    High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas

    Not yet reported Charite University, Berlin, Germany 30 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT01182415

    High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma

    Not yet reported Massachusetts General Hospital 30 participants Est. completion 2016-12 2 sites Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma, CNS Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01220544

    Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells

    Not yet reported, Not yet reported Charite University, Berlin, Germany 30 participants Est. completion 2011-10 2 sites Stand-alone
    Other conditions: Acute Myeloid Leukemias, Advanced Hematological Malignancies, Indication for Allogeneic Stem Cell Transplantation, no HLA-identical Donor Available
    View official trial listing →
  • Status unknown NCT NCT01342237

    Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors

    Not yet reported Seoul National University Hospital 33 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Brain Tumors
    View official trial listing →
  • Terminated NCT NCT01350258

    Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 8 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Hematologic Malignancies, Acute Leukemia, Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myeloma, Chronic Myelogenous (or Myeloid) Leukemia (CML) Resistant to STI Therapy
    View official trial listing →
  • Completed NCT NCT01362452

    Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells

    Not yet reported M.D. Anderson Cancer Center 5 participants Est. completion 2017-07-25 1 site
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01423500

    ALL-SCT BFM International- HSCT in Children and Adolescents With ALL

    Not yet reported St. Anna Kinderkrebsforschung 405 participants Est. completion 2016-09 24 sites
    Other conditions: Lymphoblastic Leukemia, Acute, Childhood;
    View official trial listing →
  • Status unknown NCT NCT01423747

    Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia

    Not yet reported St. Anna Kinderkrebsforschung 400 participants Est. completion 2016-09 24 sites
    Other conditions: Lymphoblastic Leukemia, Acute, Childhood;
    View official trial listing →
  • Active, not recruiting NCT NCT01461837

    Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

    Not yet reported New York Medical College 21 participants Est. completion 2026-12 6 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT01471067

    Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    Not yet reported M.D. Anderson Cancer Center 33 participants Est. completion 2017-04-25 1 site Stand-alone
    Other conditions: Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplantation Infection, Transplantation, Bone Marrow
    View official trial listing →
  • Completed NCT NCT01505569

    Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

    Not yet reported Masonic Cancer Center, University of Minnesota 44 participants Est. completion 2024-02-01 1 site
    Obstructive sleep apnea Other conditions: Ewing's Family Tumors, Renal Tumors, Hepatoblastoma, Soft Tissue Sarcoma, Primary Malignant Brain Neoplasms, Retinoblastoma, Medulloblastoma, Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET), Atypical Teratoid/Rhabdoid Tumor (AT/RT), CNS Tumors, Germ Cell Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT01511562

    Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

    Not yet reported Alliance for Clinical Trials in Oncology 113 participants Est. completion 2027-05-02 126 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT01598025

    Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    Not yet reported Memorial Sloan Kettering Cancer Center 3 participants Est. completion 2017-10-16 1 site Stand-alone
    Other conditions: Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT01646034

    High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer

    Not yet reported The Netherlands Cancer Institute 74 participants Est. completion 2026-10 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01682226

    Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies

    Not yet reported Memorial Sloan Kettering Cancer Center 84 participants Est. completion 2021-01-08 1 site Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndrome, Lymphoma
    View official trial listing →
  • Completed NCT NCT01690520

    Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

    Not yet reported Nohla Therapeutics, Inc. 163 participants Est. completion 2020-05-29 8 sites Stand-alone
    Other conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT01746849

    Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported Memorial Sloan Kettering Cancer Center 82 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Leukemia, Multiple Myeloma, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01786018

    Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas

    Not yet reported Azienda Ospedaliera San Giovanni Battista 42 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: B-cell Lymphoma Refractory
    View official trial listing →
  • Completed NCT NCT01807611

    Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy

    Not yet reported St. Jude Children's Research Hospital 82 participants Est. completion 2021-09-27 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01810926

    T&B Depletion Non Malignant

    Not yet reported Franco Locatelli 130 participants Est. completion 2016-10 4 sites Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT01814475

    Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

    Not yet reported Gruppo Italiano Trapianto di Midollo Osseo 62 participants Est. completion 2016-12-31 21 sites Stand-alone
    Other conditions: Myelofibrosis
    View official trial listing →
  • Completed NCT NCT01814488

    A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia

    Not yet reported Gruppo Italiano Trapianto di Midollo Osseo 101 participants Est. completion 2017-06-30 30 sites Stand-alone
    Other conditions: Acute Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT01821781

    Immune Disorder HSCT Protocol

    Not yet reported Washington University School of Medicine 20 participants Est. completion 2026-04 1 site Stand-alone
    Other conditions: Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease, X-linked Agammaglobulinemia, Wiskott-Aldrich Syndrome, Hyper-IgM, DiGeorge Syndrome, Chediak-Higashi Syndrome, Common Variable Immune Deficiency, Immune Dysregulatory Disorders, Hemophagocytic Lymphohistiocytosis, IPEX, Autoimmune Lymphoproliferative Syndrome, X-linked Lymphoproliferative Syndrome
    View official trial listing →
  • Completed NCT NCT01858740

    Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children

    Not yet reported Fred Hutchinson Cancer Center 20 participants Est. completion 2023-07-30 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome With Excess Blasts-2, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Refractory Adult Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT01895244

    Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis

    Not yet reported University Hospital Tuebingen 44 participants Est. completion 2024-06 1 site Stand-alone
    Other conditions: Scleroderma, Cardiac Involvement, Autologous Stem Cell Transplantation
    View official trial listing →
  • Terminated NCT NCT02025881

    Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma

    Not yet reported, Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 29 participants Est. completion 2020-10-25 13 sites Stand-alone
    Other conditions: High-risk Medulloblastoma
    View official trial listing →
  • Status unknown NCT NCT02049580

    Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas

    Not yet reported Istituto Clinico Humanitas 47 participants Est. completion 2016-11 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT02053545

    Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion

    Not yet reported, Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago Est. completion 2017-05-11 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, MDS
    View official trial listing →
  • Status unknown NCT NCT02061800

    CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    Not yet reported, Not yet reported Diane George 14 participants Est. completion 2026-07 1 site
    Other conditions: Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS), Juvenile Myelomonocytic Leukemia (JMML), Acute Lymphoblastic Leukemia (ALL), Lymphoma (Hodgkin's and Non-Hodgkin's)
    View official trial listing →
  • Completed NCT NCT02165007

    Haploidentical Hematopoietic Stem Cell Transplantation

    Not yet reported Catherine Bollard 7 participants Est. completion 2024-10 1 site Stand-alone
    Other conditions: Sickle Cell-thalassemia Disease, Thalassemia
    View official trial listing →
  • Active, not recruiting NCT NCT02171104

    MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis

    Not yet reported Masonic Cancer Center, University of Minnesota 149 participants Est. completion 2029-07-14 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome, Maroteaux Lamy Syndrome, Sly Syndrome, Alpha-Mannosidosis, Fucosidosis, Glycoprotein Metabolic Disorders, Sphingolipidoses, Recessive Leukodystrophies, Globoid Cell Leukodystrophy, Metachromatic Leukodystrophy, Niemann-Pick B, Niemann-Pick C Subtype 2, Sphingomyelin Deficiency, Peroxisomal Disorders, Adrenoleukodystrophy With Cerebral Involvement, Zellweger Syndrome, Neonatal Adrenoleukodystrophy, Infantile Refsum Disease, Acyl-CoA Oxidase Deficiency, D-Bifunctional Enzyme Deficiency, Multifunctional Enzyme Deficiency, Alpha-methylacyl-CoA Racmase Deficiency, Mitochondrial Neurogastrointestingal Encephalopathy, Severe Osteopetrosis, Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation), Inherited Metabolic Disorders
    View official trial listing →
  • Terminated NCT NCT02199041

    Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen

    Not yet reported St. Jude Children's Research Hospital 24 participants Est. completion 2017-05-23 1 site Stand-alone
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT02220985

    Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

    Not yet reported Fred Hutchinson Cancer Center 84 participants Est. completion 2025-05-01 2 sites Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Undifferentiated Leukemia, Allogeneic Hematopoietic Stem Cell Transplant Recipient, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blastic Plasmacytoid Dendritic Cell Neoplasm, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Donor, Lymphoblastic Lymphoma, Myelodysplastic Syndrome With Excess Blasts, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome With Excess Blasts-2, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission
    View official trial listing →
  • Terminated NCT NCT02259348

    Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

    Not yet reported St. Jude Children's Research Hospital 12 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myeloid Sarcoma, Chronic Myelogenous Leukemia (CML), Juvenile Myelomonocytic Leukemia (JMML), Myelodysplastic Syndrome (MDS), Non-Hodgkin Lymphoma (NHL)
    View official trial listing →
  • Active, not recruiting NCT NCT02323867

    Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies

    Not yet reported Children's Hospital of Philadelphia 140 participants Est. completion 2027-10 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myelodysplasia
    View official trial listing →
  • Completed NCT NCT02329080

    New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

    Not yet reported International Extranodal Lymphoma Study Group (IELSG) 79 participants Est. completion 2024-03-22 36 sites Stand-alone
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02333058

    Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

    Not yet reported medac GmbH 70 participants Est. completion 2019-09-30 24 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS), Juvenile Myelomonocytic Leukaemias (JMML)
    View official trial listing →
  • Status unknown NCT NCT02333838

    Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies

    Not yet reported Assistance Publique - Hôpitaux de Paris 31 participants Est. completion 2019-05 1 site Stand-alone
    Other conditions: Leukemia, Myeloid
    View official trial listing →
  • Status unknown NCT NCT02339753

    Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation

    Not yet reported The Korean Society of Pediatric Hematology Oncology 24 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Pediatric Solid Tumor
    View official trial listing →
  • Status unknown NCT NCT02385955

    Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients

    Not yet reported Seoul National University Hospital 39 participants Est. completion 2019-04 Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Status unknown NCT NCT02386332

    A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies

    Instituto de Investigacion Sanitaria La Fe 206 participants Est. completion 2020-03
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Status unknown NCT NCT02399189

    MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma

    Not yet reported Jun Zhu 39 participants Est. completion 2019-04 1 site Stand-alone
    Other conditions: Primary Central Nervous System Lymphoma
    View official trial listing →
  • Completed NCT NCT02500550

    Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

    Not yet reported Kiadis Pharma 15 participants Est. completion 2018-12-17 11 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT02504190

    Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM)

    Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 95 participants Est. completion 2019-11-30 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02507479

    Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

    Not yet reported Sheba Medical Center 24 participants Est. completion 2019-07 2 sites Stand-alone
    Other conditions: Non Hodgkin Lymphoma, Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT02531841

    High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma

    Not yet reported University Hospital Freiburg 250 participants Est. completion 2019-12 2 sites
    Other conditions: Diffuse Large B-cell-lymphoma
    View official trial listing →
  • Completed NCT NCT02623309

    Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients

    Not yet reported Institut Paoli-Calmettes 108 participants Est. completion 2021-03-12 14 sites Stand-alone
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Completed NCT NCT02626715

    Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

    Not yet reported Randy Windreich 21 participants Est. completion 2023-04-12 1 site
    Other conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT)
    View official trial listing →
  • Terminated NCT NCT02653196

    A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors

    Not yet reported Montefiore Medical Center 1 participants Est. completion 2017-08 1 site Stand-alone
    Other conditions: Neuroepithelial Tumor, Solid Tumor, Allogeneic Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT02660281

    URMC Related Haplo-identical Donor BMT

    Not yet reported University of Rochester 74 participants Est. completion 2021-01-07 1 site
    Other conditions: Hematological Disease, Immune Deficiencies, Solid Tumors, Myelofibrosis, Multiple Myeloma, Lymphoma
    View official trial listing →
  • Completed NCT NCT02707393

    Allogeneic Stem Cell Transplantation for Children With CML

    Not yet reported, Not yet reported St. Anna Kinderkrebsforschung 13 participants Est. completion 2020-12-01 4 sites Stand-alone
    Other conditions: Chronic Myeloid Leukemia
    View official trial listing →
  • Withdrawn NCT NCT02724904

    Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma

    Not yet reported, Not yet reported Massachusetts General Hospital Est. completion 2021-12 2 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT02757885

    Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow

    Not yet reported Emory University 10 participants Est. completion 2021-12-14 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Status unknown NCT NCT02784015

    Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma

    Not yet reported Samsung Medical Center 41 participants Est. completion 2023-05 1 site Stand-alone
    Other conditions: Unresectable Localized Soft Tissue Sarcoma
    View official trial listing →
  • Status unknown NCT NCT02784054

    Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor

    Not yet reported Samsung Medical Center 25 participants Est. completion 2023-03 1 site Stand-alone
    Other conditions: Intracranial Non-germinomatous Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT02788201

    Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma

    Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2019-10-23 1 site Stand-alone
    Other conditions: Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT02790515

    Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

    Not yet reported St. Jude Children's Research Hospital 170 participants Est. completion 2026-07-01 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myeloid Sarcoma, Chronic Myeloid Leukemia (CML), Juvenile Myelomonocytic Leukemia (JMML), Myelodysplastic Syndrome (MDS), Non-Hodgkin Lymphoma (NHL)
    View official trial listing →
  • Active, not recruiting NCT NCT02810743

    Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer

    Not yet reported The Netherlands Cancer Institute 174 participants Est. completion 2033-12-01 11 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02861417

    Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

    Not yet reported M.D. Anderson Cancer Center 204 participants Est. completion 2028-08-31 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, Lymphoproliferative Disorder, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent High Risk Myelodysplastic Syndrome, Recurrent Hodgkin Lymphoma, Recurrent Myelodysplastic Syndrome, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma
    View official trial listing →
  • Completed NCT NCT02867800

    Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease

    Not yet reported Monica Bhatia 24 participants Est. completion 2023-12-30 7 sites Stand-alone
    Other conditions: Sickle Cell Disease, Graft Versus Host Disease
    View official trial listing →
  • Active, not recruiting NCT NCT02870907

    Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)

    Not yet reported Institut Curie 195 participants Est. completion 2031-03-01 27 sites Stand-alone
    Other conditions: Retinoblastoma
    View official trial listing →
  • Active, not recruiting NCT NCT02875314

    HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

    Not yet reported Parth Patel 250 participants Est. completion 2030-12 62 sites Stand-alone
    Other conditions: Medulloblastoma, Central Nervous System Embryonal Tumors
    View official trial listing →
  • Completed NCT NCT02880293

    Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor

    Not yet reported Memorial Sloan Kettering Cancer Center 44 participants Est. completion 2023-11-20 1 site Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Active, not recruiting NCT NCT02990819

    Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies

    Not yet reported Children's Hospital of Philadelphia 60 participants Est. completion 2027-12 1 site
    Other conditions: Immunodeficiencies, Immune Dysregulation Syndromes
    View official trial listing →
  • Completed NCT NCT03035422

    Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia

    Not yet reported Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 24 participants Est. completion 2021-12-18 1 site
    Other conditions: Refractory Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT03061656

    Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma

    Not yet reported Samsung Medical Center 40 participants Est. completion 2018-12-31 Stand-alone
    Other conditions: High Risk Neuroblastoma
    View official trial listing →
  • Completed NCT NCT03079089

    Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders

    Not yet reported Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 40 participants Est. completion 2023-09-11 1 site
    Other conditions: Refractory or Relapsed Lymphoid Haemopathy
    View official trial listing →
  • Terminated NCT NCT03165292

    Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 34 participants Est. completion 2024-03-28 9 sites Stand-alone
    Other conditions: Very High Risk Neuroblastoma
    View official trial listing →
  • Completed NCT NCT03240731

    HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease

    Not yet reported Centre Hospitalier Intercommunal Creteil 25 participants Est. completion 2024-04-08 7 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT03263559

    Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)

    Not yet reported Medical College of Wisconsin 95 participants Est. completion 2025-01-29 32 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT03342196

    Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation

    Not yet reported Case Comprehensive Cancer Center 40 participants Est. completion 2024-06-12 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT03346096

    TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) for AutoSCT in Lymphoma

    Not yet reported Sheba Medical Center 50 participants Est. completion 2024-06-30 1 site Stand-alone
    Other conditions: Malignant Lymphoma
    View official trial listing →
  • Terminated NCT NCT03367546

    Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases

    Not yet reported Masonic Cancer Center, University of Minnesota 5 participants Est. completion 2022-12-19 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders, Cerebral Adrenoleukodystrophy, Inherited Metabolic Disorders
    View official trial listing →
  • Active, not recruiting NCT NCT03399773

    Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

    Not yet reported Fred Hutchinson Cancer Center 31 participants Est. completion 2027-04-02 1 site Stand-alone
    Other conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid Cell Neoplasm, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts
    View official trial listing →
  • Completed NCT NCT03434704

    Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole

    Not yet reported Ciceri Fabio 10 participants Est. completion 2019-10-13 1 site Stand-alone
    Other conditions: Transplant-Related Hematologic Malignancy, Leukemia, Acute, Myelodysplastic Syndromes, Graft Vs Host Disease, Fungal Infection
    View official trial listing →
  • Completed NCT NCT03513328

    Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation

    Not yet reported, Not yet reported University of Florida 6 participants Est. completion 2023-02-19 1 site Stand-alone
    Other conditions: Bone Marrow Failure Syndrome, Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia, Acquired Neutropenia in Newborn, Acquired Anemia Hemolytic, Acquired Thrombocytopenia, Hemophagocytic Lymphohistiocytoses, Wiskott-Aldrich Syndrome, Chronic Granulomatous Disease, Common Variable Immunodeficiency, X-linked Lymphoproliferative Disease, Severe Combined Immunodeficiency, Hurler Syndrome, Mannosidosis, Adrenoleukodystrophy
    View official trial listing →
  • Active, not recruiting NCT NCT03597594

    Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)

    Not yet reported, Not yet reported St. Jude Children's Research Hospital 4 participants Est. completion 2028-07-01 1 site
    Other conditions: Severe Combined Immunodeficiency
    View official trial listing →
  • Completed NCT NCT03609840

    Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

    University of California, San Francisco 25 participants Est. completion 2023-07-31 1 site
    Other conditions: Hematologic Malignancies, Nonmalignant Diseases, Immune Deficiency, Hemoglobinopathies, Genetic Inborn Errors of Metabolism, Fanconi Anemia, Thalassemia, Sickle Cell Disease
    View official trial listing →
  • Terminated NCT NCT03615105

    Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors

    Not yet reported Memorial Sloan Kettering Cancer Center 9 participants Est. completion 2024-03-06 1 site Stand-alone
    Other conditions: Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Terminated NCT NCT03615144

    TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors

    Not yet reported Memorial Sloan Kettering Cancer Center 1 participants Est. completion 2020-11-13 1 site
    Other conditions: Non-Malignant Hematologic Disorders
    View official trial listing →
  • Active, not recruiting NCT NCT03779854

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

    Not yet reported Fred Hutchinson Cancer Center 45 participants Est. completion 2028-12-31 9 sites Stand-alone
    Other conditions: Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blasts Under 25 Percent of Bone Marrow Nucleated Cells, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome/Acute Myeloid Leukemia, Burkitt Leukemia, Chronic Monocytic Leukemia, Lymphoblastic Lymphoma, Mast Cell Leukemia, Myeloproliferative Neoplasm
    View official trial listing →
  • Completed NCT NCT03786783

    Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

    Not yet reported National Cancer Institute (NCI) 42 participants Est. completion 2026-03-31 10 sites Stand-alone
    Other conditions: Ganglioneuroblastoma, High Risk Neuroblastoma
    View official trial listing →
  • Active, not recruiting NCT NCT03849651

    TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 69 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), NK-Cell Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma (NHL), Juvenile Myelomonocytic Leukemia (JMML), Chronic Myeloid Leukemia (CML)
    View official trial listing →
  • Completed NCT NCT03885947

    VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

    Not yet reported Alla Keyzner 7 participants Est. completion 2021-03-10 1 site Stand-alone
    Other conditions: Hematological Malignancy, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, Myelodysplastic Syndromes, Non-Hodgkin Lymphoma, Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT03902665

    Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 19 participants Est. completion 2024-06-30 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Adult
    View official trial listing →
  • Active, not recruiting NCT NCT03913026

    UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia

    Not yet reported Ciusss de L'Est de l'Île de Montréal 30 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: High Risk Hematologic Malignancy, Cord Blood Transplant
    View official trial listing →
  • Terminated NCT NCT04067180

    Randomized Clinical Study Assessing Haplo vs. URD in AML

    Not yet reported Karolinska Institutet 18 participants Est. completion 2022-08-26 9 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT04083170

    Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers

    Not yet reported Fred Hutchinson Cancer Center 1 participants Est. completion 2022-11-30 5 sites Stand-alone
    Other conditions: Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid Cell Neoplasm, HIV Infection, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts, Non-Hodgkin Lymphoma, Refractory Anemia
    View official trial listing →
  • Completed NCT NCT04103879

    US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia

    Not yet reported ExCellThera inc. 30 participants Est. completion 2026-02-28 3 sites Stand-alone
    Other conditions: High Risk Hematological Malignancy, Cord Blood Transplant
    View official trial listing →
  • Completed NCT NCT04121507

    ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy

    Not yet reported GWT-TUD GmbH 60 participants Est. completion 2023-02-02 13 sites
    Other conditions: Aggressive Non-hodgkin Lymphoma (aNHL), Lymphoma, B-Cell, Lymphoma, T-Cell
    View official trial listing →
  • Completed NCT NCT04151706

    CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML

    Not yet reported Robert Lowsky 7 participants Est. completion 2023-09-08 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Acute Leukemia, Chronic Myeloid Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT04217278

    A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

    Not yet reported, Not yet reported University of Birmingham 333 participants Est. completion 2026-05 14 sites Stand-alone
    Other conditions: Acute Myeloid Leukaemia, High-risk Myelodysplastic Syndrome
    View official trial listing →
  • Withdrawn NCT NCT04282174

    CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies

    Not yet reported Baptist Health South Florida Est. completion 2030-03-01 1 site Stand-alone
    Other conditions: Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT04362293

    Reduced Intensity Transplantation for Severe Sickle Cell Disease

    Not yet reported St. Jude Children's Research Hospital 46 participants Est. completion 2029-08-01 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Withdrawn NCT NCT04521946

    Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

    Not yet reported M.D. Anderson Cancer Center Est. completion 2022-12-20 Stand-alone
    Other conditions: Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, Central Nervous System Germ Cell Tumor, Choroid Plexus Carcinoma, Intracranial Myeloid Sarcoma, Malignant Brain Neoplasm, Malignant Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, Recurrent Anaplastic Ependymoma, Recurrent Atypical Teratoid/Rhabdoid Tumor, Recurrent Malignant Brain Neoplasm, Recurrent Malignant Glioma, Recurrent Medulloblastoma, Recurrent Primitive Neuroectodermal Tumor
    View official trial listing →
  • Terminated NCT NCT04530487

    Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

    Not yet reported M.D. Anderson Cancer Center 1 participants Est. completion 2024-08-26 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small Round Cell Tumor, Recurrent Malignant Peripheral Nerve Sheath Tumor, Recurrent Malignant Solid Neoplasm, Recurrent Neuroblastoma, Refractory Desmoplastic Small Round Cell Tumor, Refractory Malignant Peripheral Nerve Sheath Tumor, Refractory Malignant Solid Neoplasm, Refractory Neuroblastoma
    View official trial listing →
  • Status unknown NCT NCT04728490

    Haplo-identical Transplantation in Patients With Myelofibrosis - A Phase 2 Prospective Multicentric Prospective Study

    Not yet reported Assistance Publique - Hôpitaux de Paris 28 participants Est. completion 2024-01-30 Stand-alone
    Other conditions: Myelofibrosis
    View official trial listing →
  • Active, not recruiting NCT NCT04859946

    Itacitinib for the Prevention of Graft Versus Host Disease

    Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2027-04-01 1 site Stand-alone
    Other conditions: Hematologic and Lymphocytic Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT04872595

    A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant

    Not yet reported Memorial Sloan Kettering Cancer Center 59 participants Est. completion 2027-04 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), Myelodysplastic Syndromes (MDS)
    View official trial listing →
  • Active, not recruiting NCT NCT04931368

    OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma

    Not yet reported Klinikum Stuttgart 331 participants Est. completion 2028-11 1 site Stand-alone
    Other conditions: Primary Central Nervous System Lymphoma
    View official trial listing →
  • Completed NCT NCT04990323

    US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies

    Not yet reported, Not yet reported ExCellThera inc. 13 participants Est. completion 2025-12-31 1 site
    Other conditions: High Risk Myeloid Malignancies, Cord Blood Transplant
    View official trial listing →
  • Status unknown NCT NCT05021770

    Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma

    Not yet reported, Not yet reported Huiqiang Huang 29 participants Est. completion 2024-06 1 site Stand-alone
    Other conditions: Refractory and Relapsed Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT05088356

    Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

    Not yet reported Stanford University 66 participants Est. completion 2028-05 1 site Stand-alone
    Other conditions: Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders
    View official trial listing →
  • Terminated NCT NCT05167370

    High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors

    Not yet reported Children's Hospital Medical Center, Cincinnati 2 participants Est. completion 2012-04-24 1 site Stand-alone
    Other conditions: Solid Tumors, Brain Tumors
    View official trial listing →
  • Not yet recruiting NCT NCT05303727

    Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 64 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Status unknown NCT NCT05398224

    R-MTX-zanbrutinib in Secondary CNS Lymphoma

    Not yet reported Peking University 45 participants Est. completion 2024-05-26 1 site Stand-alone
    Other conditions: Secondary Central Nervous System Lymphoma
    View official trial listing →
  • Status unknown NCT NCT05425654

    RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL

    Not yet reported National Research Center for Hematology, Russia 30 participants Est. completion 2026-05 1 site Stand-alone
    Other conditions: Primary CNS Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT05457556

    Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome

    Not yet reported Children's Oncology Group 66 participants Est. completion 2027-07-07 63 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT05565105

    CD34+ Transplants for Leukemia and Lymphoma

    Not yet reported Guenther Koehne 100 participants Est. completion 2033-06 1 site Stand-alone
    Other conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute
    View official trial listing →
  • Terminated NCT NCT05579769

    Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.

    Not yet reported St. Jude Children's Research Hospital 3 participants Est. completion 2024-05-08 1 site Stand-alone
    Other conditions: Hematologic Malignancy, Myeloid Malignancy
    View official trial listing →
  • Status unknown NCT NCT05598593

    Modified TBF Regimen as Conditioning Regimen Prior to Allo-HSCT for T-ALL/LBL

    Not yet reported First Affiliated Hospital of Zhejiang University 70 participants Est. completion 2025-09 1 site Stand-alone
    Other conditions: Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    View official trial listing →
  • Status unknown NCT NCT05667402

    Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 50 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Central Nervous System Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT05854225

    Thiotepa Incorporating TBI/Cy Conditioning Regimen for EBV-HLH With Central Nervous System Involvement

    Not yet reported Beijing Friendship Hospital 20 participants Est. completion 2025-01 1 site
    Other conditions: HLH
    View official trial listing →
  • Completed NCT NCT06376292

    A Prospective Single Arm Phase II Exploratory Study on the Combination of Whole Brain Radiotherapy, Thiotepa Intrathecal Injection and Systemic Treatment of Primary Diseases in the Treatment of Solid Tumor Leptomeningeal Metastasis

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 58 participants Est. completion 2025-09-01 1 site Stand-alone
    Other conditions: Solid Tumor Leptomeningeal Metastasis
    View official trial listing →
  • Not yet recruiting NCT NCT06385808

    Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 37 participants Est. completion 2026-12-31 Stand-alone
    Other conditions: Relapse Leukemia, Refractory Acute Myeloid Leukemia, Conditioning, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT06468267

    RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.

    Not yet reported Xianmin Song, MD 50 participants Est. completion 2026-07-15 1 site Stand-alone
    Other conditions: Peripheral T Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT06625359

    High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma

    Not yet reported Seoul National University Hospital 17 participants Est. completion 2024-09-30 1 site Stand-alone
    Other conditions: Central Nervous System Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT06646211

    High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)

    Not yet reported Sun Yat-sen University 30 participants Est. completion 2028-01-01 1 site Stand-alone
    Other conditions: Primary Central Nervous System Lymphoma (PCNSL), Non Hodgkin Lymphoma (NHL)
    View official trial listing →
  • Suspended NCT NCT06680661

    ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

    Not yet reported Leland Metheny 20 participants Est. completion 2028-10-31 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphatic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndromes, Myelodysplastic Syndrome Other, Chronic Myelomonocytic Leukemia, Lymphoma, Hodgkin Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT06734663

    Clinical Outcomes of Sutured Versus Sutureless Conjunctival Autograft in Primary Pterygium Excision

    Not yet reported Assiut University 70 participants Est. completion 2025-09-01 2 sites
    Other conditions: Pterygium of Conjunctiva and Cornea, Pterygium of Both Eyes, Pterygium
    View official trial listing →
  • Not yet recruiting NCT NCT06900192

    A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis

    Not yet reported Stanford University 10 participants Est. completion 2029-08 Stand-alone
    Other conditions: Primary Progressive Multiple Sclerosis, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive
    View official trial listing →
  • Not yet recruiting NCT NCT06901999

    Methotrexate or Thiotepa Combined With R-CHOP and Orelabrutinib in CNSL Patients

    Not yet reported Ruijin Hospital 23 participants Est. completion 2028-11 Stand-alone
    Other conditions: CNS Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07259161

    Modified Conditioning Regimen for CML-BP

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 40 participants Est. completion 2029-09-14 Stand-alone
    Other conditions: CML,Blast Phase, HSCT
    View official trial listing →
  • Not yet recruiting NCT NCT07276737

    Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 37 participants Est. completion 2029-12-30 Stand-alone
    Other conditions: NK T-Cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07291102

    Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

    Not yet reported Nationwide Children's Hospital 96 participants Est. completion 2038-10 2 sites Stand-alone
    Other conditions: Medulloblastoma
    View official trial listing →
  • Not yet recruiting NCT NCT07372885

    GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia

    Not yet reported, Not yet reported University of Manchester 50 participants Est. completion 2029-12-31 3 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Stem Cell Transplantation, Stem Cell Transplantation, Hematopoietic, Cord Blood Stem Cell Transplantation, Cellular Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT07441967

    The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 44 participants Est. completion 2028-12-30 Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT07493486

    IT-TT as an Effective and Well-Tolerated Strategy for CNS Prop in High-Risk DLBCL: a Prospective Ph II Study

    Not yet reported Zhejiang Cancer Hospital 31 participants Est. completion 2023-08-31 1 site Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Intrathecal Chemotherapy
    View official trial listing →
  • Enrolling by invitation NCT NCT07539662

    Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 8 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: ALS (Amyotrophic Lateral Sclerosis)
    View official trial listing →
  • Not yet recruiting NCT NCT07542418

    Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 204 participants Est. completion 2028-10-20 Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Not yet recruiting NCT NCT07562568

    SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

    Not yet reported The First Affiliated Hospital of Soochow University 160 participants Est. completion 2030-06 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell, Conditioning Therapy, SHR2554, Azacytidine
    View official trial listing →
  • Not yet recruiting NCT NCT07563920

    TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 93 participants Est. completion 2030-06 Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Not yet recruiting NCT NCT07660783

    Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

    Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2035-09 2 sites
    Other conditions: Bone Marrow Failure, Hemoglobinopathies, Primary Immune Deficiency (PID), Autoimmune Cytopenia, Immune Dysregulation, Hemophagocytic Lymphohistiocytosis (HLH), Non Malignant Disorders
    View official trial listing →
  • Not yet recruiting NCT NCT07677813

    Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma

    Not yet reported Ou Bai, MD/PHD 66 participants Est. completion 2031-12-31 1 site Stand-alone
    Other conditions: DLBCL - Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07757685

    Autologous Hematopoietic Stem Cell Transplantation for Neurological Damage Associated With Hereditary Homocysteine Remethylation Disorders

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 50 participants Est. completion 2030-07-31 2 sites Stand-alone
    Other conditions: Hereditary Homocysteine Remethylation Disorder
    View official trial listing →
  • Not yet recruiting NCT NCT07759102

    Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma

    Not yet reported University of California, Davis 20 participants Est. completion 2033-09-01 1 site Stand-alone
    Other conditions: Recurrent Multiple Myeloma, Refractory Multiple Myeloma
    View official trial listing →
  • Not yet recruiting NCT NCT07778940

    Thiotepa Administration Via Ommaya Reservoir for Leptomeningeal Metastases in Non-Small Cell Lung Cancer Resistant to EGFR-TKI.

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 50 participants Est. completion 2028-03 1 site Stand-alone
    Other conditions: Leptomeningeal Metastasis
    View official trial listing →
  • Not yet recruiting NCT NCT07812493

    Pirtobrutinib Plus Methotrexate-Based Chemoimmunotherapy for Systemic DLBCL With CNS Involvement

    Not yet reported Pengpeng Xu 24 participants Est. completion 2030-09-01 1 site Stand-alone
    Other conditions: Pirtobrutinib, Immunochemotherapy, DLBCL - Diffuse Large B Cell Lymphoma, CNS Involvement of Systemic Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07819812

    Thiotepa-Based Conditioning for Haploidentical HSCT in Older Patients With Severe Aplastic Anemia

    Not yet reported Peking University People's Hospital 10 participants Est. completion 2029-12-31 Stand-alone
    Other conditions: Severe Aplastic Anemia, Aplastic Anaemia, Hematopoietic Cell Transplant
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Thiotepa, TESPA, TSPA

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.